Design and synthesis of a novel family of triazine-based inhibitors of sorbitol dehydrogenase with oral activity: 1-[4-[3R,5S-dimethyl-4-(4-methyl-[1,3,5]triazin-2-yl)-piperazin-1-yl]-[1,3,5]triazin-2-yl]-(R) ethanol.
暂无分享，去创建一个
P. Oates | J. Coutcher | D. Beebe | Edward L. Conn | B. Mylari | W. Zembrowski | N. Brackett | Gregory J. Withbroe | B. L. Mylari
[1] P. Oates,et al. A sorbitol dehydrogenase inhibitor of exceptional in vivo potency with a long duration of action: 1-(R)-[4-[4-(4,6-dimethyl[1,3,5]triazin-2-yl)- 2R,6S-dimethylpiperazin-1-yl]pyrimidin-2- yl]ethanol. , 2002, Journal of medicinal chemistry.
[2] M. Chu-Moyer,et al. Orally-effective, long-acting sorbitol dehydrogenase inhibitors: synthesis, structure-activity relationships, and in vivo evaluations of novel heterocycle-substituted piperazino-pyrimidines. , 2002, Journal of medicinal chemistry.
[3] P. Oates,et al. Sorbitol dehydrogenase inhibitors (SDIs): a new potent, enantiomeric SDI, 4-[2-1R-hydroxy-ethyl)-pyrimidin-4-yl]piperazine-1-sulfonic acid dimethylamide. , 2001, Journal of medicinal chemistry.
[4] N. Calcutt,et al. Effects of sorbitol dehydrogenase deficiency on nerve conduction in experimental diabetic mice. , 1998, Diabetes.
[5] J. Nyengaard,et al. Inhibition of Sorbitol Dehydrogenase: Effects on Vascular and Neural Dysfunction in Streptozocin-Induced Diabetic Rats , 1995, Diabetes.
[6] J. Nyengaard,et al. Hyperglycemic Pseudohypoxia and Diabetic Complications , 1993, Diabetes.
[7] U. Graf,et al. Welkstoffe und Antibiotika. 39. Mitteilung [1]. Fusarinolsäure , 1971 .
[8] B. Hackley,et al. The synthesis of oximes. II , 1967 .
[9] Rln Harris. The synthesis of alkyl- and aryl-substituted 1,3,5-triazines , 1981 .